PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.01%
Revenue growth of 1.01% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
-129.16%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-2648.08%
Negative EBIT growth while Healthcare median is 2.36%. Seth Klarman would check if external or internal factors caused the decline.
-2648.08%
Negative operating income growth while Healthcare median is 2.52%. Seth Klarman would check if structural or cyclical issues are at play.
-1840.05%
Negative net income growth while Healthcare median is 3.33%. Seth Klarman would investigate factors dragging net income down.
-1840.00%
Negative EPS growth while Healthcare median is 6.16%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-1840.00%
Negative diluted EPS growth while Healthcare median is 6.60%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.63%
Share growth above Healthcare median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.63%
Diluted share growth above 2x Healthcare median. Jim Chanos would suspect undue issuance or heavy employee stock compensation.
No Data
No Data available this quarter, please select a different quarter.
-163.79%
Negative OCF growth while Healthcare median is 6.23%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-178.99%
Negative FCF growth while Healthcare median is 7.29%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
No Data
No Data available this quarter, please select a different quarter.
297.40%
5Y CAGR of 297.40% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
-52.47%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
-297.77%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-3403.96%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
83.35%
3Y OCF/share growth of 83.35% while Healthcare median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-51280.40%
Negative 10Y net income/share CAGR vs. Healthcare median of 15.52%. Seth Klarman might see a fundamental problem if peers maintain growth.
-2688.92%
Negative 5Y CAGR while Healthcare median is 9.24%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-9959.44%
Negative 3Y CAGR while Healthcare median is 6.31%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
6257.60%
Equity/share CAGR of 6257.60% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
29.59%
5Y equity/share CAGR of 29.59% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
-12.97%
Negative 3Y equity/share growth while Healthcare median is 0.00%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.67%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-15.83%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
-20.07%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-24.48%
Negative BV/share change while Healthcare median is -4.24%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-0.85%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
3.64%
R&D growth of 3.64% while Healthcare median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
-11.81%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.